Response of recurrent BRAFV600E mutated ganglioglioma to Vemurafenib as single agent

被引：0
|
作者：
Francesca del Bufalo
Andrea Carai
Lorenzo Figà-Talamanca
Benedetta Pettorini
Conor Mallucci
Felice Giangaspero
Manila Antonelli
Manuela Badiali
Loredana Moi
Giuseppe Bianco
Antonella Cacchione
Franco Locatelli
Elisabetta Ferretti
Angela Mastronuzzi
机构：
[1] Bambino Gesù Children’s Hospital,Department of Hematology/Oncology and Stem Cell Transplantation
[2] IRCCS,Department of Neuroscience and Neurorehabilitation
[3] Neurosurgery Unit,Department of Radiology
[4] Bambino Gesù Children’s Hospital,Paediatric Neurosurgery Department
[5] IRCCS,Department of Radiological, Oncological and Pathological Science
[6] Unit of Neuroradiology,Neuromed Institute
[7] Bambino Gesù Children’s Hospital,Bone Marrow Transplantation Unit
[8] IRCCS,Public Health, Clinic and Molecular Medicine Department
[9] Alder Hey Children’s NHS Foundation Trust,Pharmacy Unit
[10] Sapienza University,University of Pavia
[11] IRCCS,Department of Experimental Medicine
[12] Microcitemico Children’s Hospital,undefined
[13] Microcitemico Children’s Hospital,undefined
[14] Bambino Gesù Children’s Hospital,undefined
[15] IRCCS,undefined
[16] Strada Nuova,undefined
[17] Sapienza University,undefined
来源：
Journal of Translational Medicine | / 12卷
关键词：
Low Grade Glioma; Ganglioglioma; MAP Kinase pathway; BRAF V600E; Vemurafenib;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Response of recurrent BRAFV600E mutated ganglioglioma to Vemurafenib as single agent
    del Bufalo, Francesca
    Carai, Andrea
    Fig-Talamanca, Lorenzo
    Pettorini, Benedetta
    Mallucci, Conor
    Giangaspero, Felice
    Antonelli, Manila
    Badiali, Manuela
    Moi, Loredana
    Bianco, Giuseppe
    Cacchione, Antonella
    Locatelli, Franco
    Ferretti, Elisabetta
    Mastronuzzi, Angela
    JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12
  • [2] BRAFv600E INHIBITOR(VEMURAFENIB) IN PEDIATRIC PATIENTS AFFECTED BY BRAFv600E MUTATED GLIOMAS
    del Bufalo, Francesca
    Cacchione, Antonella
    Carai, Andrea
    Antonelli, Manila
    Giangaspero, Felice
    Ferretti, Elisabetta
    Catanzaro, Giuseppina
    Miele, Evelina
    Badiali, Manuela
    Pettorini, Benedetta
    Mastronuzzi, Angela
    NEURO-ONCOLOGY, 2016, 18 : 24 - 24
  • [3] Preclinical Evaluation of Vemurafenib as Therapy for BRAFV600E Mutated Sarcomas
    Gouravan, Sarina
    Meza-Zepeda, Leonardo A.
    Myklebost, Ola
    Stratford, Eva W.
    Munthe, Else
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (04)
  • [4] The BRAFV600E kinase inhibitor vemurafenib induces endoplasmic reticulum stress-mediated apoptosis in BRAFV600E mutated melanoma cells
    Beck, D.
    Niessner, H.
    Flaherty, K.
    Vasseur, S.
    Iovanna, J. L.
    Bauer, J.
    Weide, B.
    Kulms, D.
    Schadendorf, D.
    Garbe, C.
    Meier, F.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2011, 9 (09): : 792 - 792
  • [5] Vemurafenib in Pediatric Patients With BRAFV600E Mutated High-Grade Gliomas
    Bautista, Francisco
    Paci, Angelo
    Minard-Colin, Veronique
    Dufour, Christelle
    Grill, Jacques
    Lacroix, Ludovic
    Varlet, Pascale
    Valteau-Couanet, Dominique
    Geoerger, Birgit
    PEDIATRIC BLOOD & CANCER, 2014, 61 (06) : 1101 - 1103
  • [6] RAPID SYMPTOMATIC IMPROVEMENT FOR A PATIENT TREATED WITH BRAF INHIBITION FOR BRAFV600E MUTATED GANGLIOGLIOMA
    Cantor, Evan
    Cochrane, Anne
    Morris, Stephanie
    Meyer, Ashley
    Ogle, Andrea
    Shatara, Margaret
    Cluster, Andrew
    Deng, Mai
    Abdelbaki, Mohamed S.
    Brossier, Nicole M.
    NEURO-ONCOLOGY, 2022, 24 : 94 - 94
  • [7] BRAFV600E mutation is a negative prognosticator in pediatric ganglioglioma
    Dahiya, Sonika
    Haydon, Devon H.
    Alvarado, David
    Gurnett, Christina A.
    Gutmann, David H.
    Leonard, Jeffrey R.
    ACTA NEUROPATHOLOGICA, 2013, 125 (06) : 901 - 910
  • [8] BRAFV600E mutation is a negative prognosticator in pediatric ganglioglioma
    Sonika Dahiya
    Devon H. Haydon
    David Alvarado
    Christina A. Gurnett
    David H. Gutmann
    Jeffrey R. Leonard
    Acta Neuropathologica, 2013, 125 : 901 - 910
  • [9] A SAFETY STUDY OF VEMURAFENIB, AN ORAL INHIBITOR OF BRAFV600E, IN CHILDREN WITH RECURRENT/REFRACTORY BRAFV600E MUTANT BRAIN TUMORS: PNOC-002
    Nicolaides, Theo
    Nazemi, Kellie
    Crawford, John
    Kilburn, Lindsay
    Minturn, Jane
    Gajjar, Amar
    Gauvain, Karen
    Leary, Sarah
    Dhall, Girish
    Aboian, Mariam
    Robinson, Giles
    Molinaro, Annette
    Mueller, Sabine
    Prados, Michael
    NEURO-ONCOLOGY, 2017, 19 : 188 - 188
  • [10] Analysis of the biological response to the BrafV600E inhibitor Vemurafenib in melanoma cell lines
    Borst, A.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 (09): : 955 - 955
12345